Malaria

A 24-year-old man in Uganda's central Mubende district showed symptoms and later died.

Oxford says its vaccine, called R21/Matrix-M, is likely more effective than Mosquirix in preventing the disease that kills about 600,000 a year.

Malaria is far more deadly than COVID-19 in Africa. It killed 386,000 Africans in 2019, according to a WHO estimate, compared with 212,000 confirmed deaths from COVID-19 in the past 18 months.

A German company, Biontech, is currently developing a vaccine for malaria based on COVID-19 vaccine technology.

Israel-based Zzapp Malaria has won the grand prize of $3 million in the $5M IBM Watson AI XPRIZE Challenge for their artificial intelligence-informed platform that identifies malaria hotspots.

Malaria kills more than 400,000 people yearly, most of whom are children under the age of five, and greatly impedes developing economies.

The app is designed to work even in environments where the Internet is not always available, as well as on low-cost phones.

Because of the small amount of available treatments, anti-malarial drug resistance is a significant threat.

The man was suffering from high fever and confusion * He told medical staff that he recently visited an African country.

Malaria affects more than 200 million people worldwide and killed an estimated 405,000 people in 2018 - most of them babies and children under five years old.

The United Nations AIDS agency and the WHO warned last week of stock shortages, with more than a third of the world's countries already saying they are at risk of running of antiretrovirals.